Vaxart Total Assets from 2010 to 2025

VXRT Stock

USD 0.52 0.05 8.77%

Vaxart Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 151.4 M in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1985-12-31

Previous Quarter

166.7 M

Current Value

166.4 M

Quarterly Volatility

99.7 M

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.1 M, Interest Expense of 1.9 M or Total Revenue of 27.3 M, as well as many indicators such as Price To Sales Ratio of 47.78, Dividend Yield of 0.0 or PTB Ratio of 23.85. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.

Check out the analysis of Vaxart Correlation against competitors.

Latest Vaxart's Total Assets Growth Pattern

Below is the plot of the Total Assets of Vaxart Inc over the last few years. Total assets refers to the total amount of Vaxart assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vaxart Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Vaxart's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 166.39 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Vaxart Total Assets Regression Statistics

	Arithmetic Mean	99,606,793
	Geometric Mean	80,198,993
	Coefficient Of Variation	57.45
	Mean Deviation	45,214,241
	Median	91,830,000
	Standard Deviation	57,226,456
	Sample Variance	3274.9T
	Range	211.2M
	R-Value	0.58
	Mean Square Error	2343.9T
	R-Squared	0.33
	Significance	0.02
	Slope	6,925,742
	Total Sum of Squares	49123T

Vaxart Total Assets History

	2025	151.4 M
	2024	166.4 M
	2023	91.8 M
	2022	153.8 M
	2021	221.2 M
	2020	152.6 M
	2019	37 M

Other Fundumenentals of Vaxart Inc

Intangibles To Total Assets

Vaxart Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Good Will	Short Term Investments	Current Deferred Revenue	Net Tangible Assets	Long Term Debt	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Property Plant Equipment	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.91	-0.52	-0.59	0.09	0.56	0.88	0.23	0.06	0.18	-0.45	0.01	0.48	0.35	0.83	-0.23	0.61	-0.23	0.4	-0.04	0.57	-0.24	0.85	0.51	-0.5
Total Stockholder Equity	0.91		-0.72	-0.28	0.02	0.21	0.95	0.05	0.07	0.14	-0.33	-0.03	0.38	0.02	0.81	-0.24	0.4	-0.27	0.58	0.06	0.31	-0.25	0.87	0.76	-0.47
Net Debt	-0.52	-0.72		-0.26	0.04	0.24	-0.82	0.31	-0.03	0.02	-0.19	0.33	0.13	0.36	-0.48	0.2	0.09	0.17	-0.62	0.02	0.35	0.2	-0.45	-0.75	0.21
Retained Earnings	-0.59	-0.28	-0.26		-0.02	-0.86	-0.23	-0.72	0.04	-0.05	0.5	-0.14	-0.44	-0.64	-0.41	-0.01	-0.77	-0.04	0.25	0.11	-0.92	0.0	-0.42	0.2	0.37
Net Receivables	0.09	0.02	0.04	-0.02		0.24	0.05	-0.21	-0.4	0.31	0.11	-0.2	0.03	0.38	0.06	-0.25	-0.08	-0.59	0.25	0.31	0.11	-0.25	-0.31	-0.42	-0.03
Total Liab	0.56	0.21	0.24	-0.86	0.24		0.22	0.42	-0.02	0.17	-0.44	0.09	0.38	0.9	0.3	-0.07	0.7	-0.03	-0.2	-0.19	0.8	-0.07	0.31	-0.36	-0.28
Total Current Assets	0.88	0.95	-0.82	-0.23	0.05	0.22		-0.08	-0.06	0.12	-0.11	-0.18	0.33	0.03	0.71	-0.2	0.32	-0.24	0.56	0.0	0.19	-0.2	0.74	0.69	-0.47
Short Term Debt	0.23	0.05	0.31	-0.72	-0.21	0.42	-0.08		0.15	-0.12	-0.49	0.36	-0.02	0.24	0.38	-0.16	0.68	0.23	-0.36	-0.19	0.69	-0.17	0.28	-0.07	-0.3
Intangible Assets	0.06	0.07	-0.03	0.04	-0.4	-0.02	-0.06	0.15		-0.29	-0.66	-0.12	-0.34	-0.11	0.04	-0.13	-0.07	0.01	-0.07	-0.12	-0.05	-0.14	0.33	0.25	0.35
Accounts Payable	0.18	0.14	0.02	-0.05	0.31	0.17	0.12	-0.12	-0.29		-0.09	0.19	0.35	0.26	0.23	-0.19	0.12	-0.36	0.33	-0.14	0.29	-0.18	0.06	-0.04	-0.22
Common Stock	-0.45	-0.33	-0.19	0.5	0.11	-0.44	-0.11	-0.49	-0.66	-0.09		-0.19	-0.2	-0.32	-0.45	0.15	-0.41	0.27	-0.02	0.14	-0.63	0.17	-0.61	-0.17	0.0
Good Will	0.01	-0.03	0.33	-0.14	-0.2	0.09	-0.18	0.36	-0.12	0.19	-0.19		0.23	0.26	0.35	-0.15	0.6	0.48	-0.06	-0.19	0.32	-0.15	0.25	0.12	-0.24
Short Term Investments	0.48	0.38	0.13	-0.44	0.03	0.38	0.33	-0.02	-0.34	0.35	-0.2	0.23		0.28	0.29	0.16	0.37	-0.16	0.1	0.0	0.56	0.15	0.39	0.11	-0.39
Current Deferred Revenue	0.35	0.02	0.36	-0.64	0.38	0.9	0.03	0.24	-0.11	0.26	-0.32	0.26	0.28		0.18	-0.07	0.61	0.05	-0.23	-0.06	0.64	-0.07	0.14	-0.48	-0.21
Net Tangible Assets	0.83	0.81	-0.48	-0.41	0.06	0.3	0.71	0.38	0.04	0.23	-0.45	0.35	0.29	0.18		-0.47	0.67	-0.12	0.48	-0.08	0.5	-0.48	0.79	0.61	-0.46
Long Term Debt	-0.23	-0.24	0.2	-0.01	-0.25	-0.07	-0.2	-0.16	-0.13	-0.19	0.15	-0.15	0.16	-0.07	-0.47		-0.33	0.05	-0.16	-0.06	-0.1	1.0	-0.12	-0.17	0.0
Capital Surpluse	0.61	0.4	0.09	-0.77	-0.08	0.7	0.32	0.68	-0.07	0.12	-0.41	0.6	0.37	0.61	0.67	-0.33		0.35	-0.12	-0.19	0.79	-0.33	0.58	0.1	-0.45
Deferred Long Term Liab	-0.23	-0.27	0.17	-0.04	-0.59	-0.03	-0.24	0.23	0.01	-0.36	0.27	0.48	-0.16	0.05	-0.12	0.05	0.35		-0.53	0.0	-0.11	0.05	0.0	0.02	0.01
Long Term Investments	0.4	0.58	-0.62	0.25	0.25	-0.2	0.56	-0.36	-0.07	0.33	-0.02	-0.06	0.1	-0.23	0.48	-0.16	-0.12	-0.53		-0.12	-0.12	-0.16	0.35	0.51	-0.12
Short Long Term Debt	-0.04	0.06	0.02	0.11	0.31	-0.19	0.0	-0.19	-0.12	-0.14	0.14	-0.19	0.0	-0.06	-0.08	-0.06	-0.19	0.0	-0.12		-0.13	-0.06	-0.1	0.0	0.0
Property Plant Equipment	0.57	0.31	0.35	-0.92	0.11	0.8	0.19	0.69	-0.05	0.29	-0.63	0.32	0.56	0.64	0.5	-0.1	0.79	-0.11	-0.12	-0.13		-0.11	0.46	-0.16	-0.42
Long Term Debt Total	-0.24	-0.25	0.2	0.0	-0.25	-0.07	-0.2	-0.17	-0.14	-0.18	0.17	-0.15	0.15	-0.07	-0.48	1.0	-0.33	0.05	-0.16	-0.06	-0.11		-0.13	-0.17	0.0
Net Invested Capital	0.85	0.87	-0.45	-0.42	-0.31	0.31	0.74	0.28	0.33	0.06	-0.61	0.25	0.39	0.14	0.79	-0.12	0.58	0.0	0.35	-0.1	0.46	-0.13		0.74	-0.42
Net Working Capital	0.51	0.76	-0.75	0.2	-0.42	-0.36	0.69	-0.07	0.25	-0.04	-0.17	0.12	0.11	-0.48	0.61	-0.17	0.1	0.02	0.51	0.0	-0.16	-0.17	0.74		-0.25
Capital Stock	-0.5	-0.47	0.21	0.37	-0.03	-0.28	-0.47	-0.3	0.35	-0.22	0.0	-0.24	-0.39	-0.21	-0.46	0.0	-0.45	0.01	-0.12	0.0	-0.42	0.0	-0.42	-0.25

Click cells to compare fundamentals

About Vaxart Financial Statements

Vaxart shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	166.4 M	151.4 M
Intangibles To Total Assets	0.05	0.05

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC